We previously conducted a phase I study with irradiated, autologous melanoma cells engineered to secrete GM-CSF by adenoviral mediated gene transfer, which demonstrated safety for patients and augmentation in anti-tumor immunity (6). Here, CSF2 is linked to neoplasm.